http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749102-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106749102-B |
| titleOfInvention | Hydroxyzine derivative and preparation method thereof, purposes and preparation |
| abstract | The invention discloses novel hydroxyzine derivatives with formula (I) structure and preparation method thereof, its purposes and preparation in anti-tumor drug.Compared with the similar anti-tumor drug Naftopidil known in the art of structure, for three kinds of common human prostate cancer cell line PC-3, LNCaP and DU145, the IC of hydroxyzine derivative of the present invention 50 Value significantly reduces.Therefore, it is expected to become a kind of more efficient antiprostate cancer. |
| priorityDate | 2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.